Bank Of America Corp Cybin Inc. Transaction History

Bank Of America Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$0.26 - $0.46 $260 - $460	1,000 Added 2.27%	45,000 $12,000
Q1 2024 May 15, 2024	BUY	$0.3 - $0.46 $1,050 - $1,610	3,500 Added 8.64%	44,000 $18,000
Q4 2023 Feb 14, 2024	BUY	$0.38 - $0.65 $15,390 - $26,325	40,500 New	40,500 $16,000
Q1 2023 May 12, 2023	SELL	$0.3 - $0.56 $193 - $361	-645 Reduced 71.19%	261 $0
Q4 2022 Feb 10, 2023	SELL	$0.26 - $0.64 $43 - $108	-169 Reduced 15.72%	906 $0
Q3 2022 Nov 14, 2022	SELL	$0.48 - $1.11 $403 - $933	-841 Reduced 43.89%	1,075 $0
Q4 2021 Feb 08, 2022	BUY	$1.13 - $2.31 $2,165 - $4,425	1,916 New	1,916 $2,000

66.1K

Ticker CYBN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 166,120,000
Market Cap $1.58B
Description
Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a phenethylamine derivative to t...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.